emtricitabine/tenofovir disoproxil "teva" 200+245 mg filmovertrukne tabletter
teva b.v. - emtricitabin, tenofovir disoproxilphosphat - filmovertrukne tabletter - 200+245 mg
efavirenz/emtricitabine/tenofovir disoproxil "glenmark" 600+200+245 mg filmovertrukne tabletter
glenmark arzneimittel gmbh - efavirenz, emtricitabin, tenofovirdisoproxilfumarat - filmovertrukne tabletter - 600+200+245 mg
emtricitabine/tenofovir disoproxil "glenmark" 200+245 mg filmovertrukne tabletter
glenmark arzneimittel gmbh - emtricitabin, tenofovir disoproxilphosphat - filmovertrukne tabletter - 200+245 mg
biktarvy
gilead sciences ireland uc - bictegravir, emtricitabine, tenofovir alafenamide, fumarate - hiv infektioner - antivirale midler til systemisk anvendelse - biktarvy is indicated for the treatment of human immunodeficiency virus 1 (hiv 1) infection in adults and paediatric patients at least 2 years of age and weighing at least 14 kg i without present or past evidence of viral resistance to the integrase inhibitor class, emtricitabine or tenofovir. (se afsnit 5.
emtricitabine/tenofovir disoproxil "accord" 200+245 mg filmovertrukne tabletter
accord healthcare b.v. - emtricitabin, tenofovirdisoproxil - filmovertrukne tabletter - 200+245 mg
emtricitabine/tenofovir disoproxil "amneal" 200+245 mg filmovertrukne tabletter
amneal pharma europe limited - emtricitabin, tenofovirdisoproxilfumarat - filmovertrukne tabletter - 200+245 mg
emtricitabine/tenofovir disoproxil "accordpharma" 200+245 mg filmovertrukne tabletter
accord healthcare b.v. - emtricitabin, tenofovirdisoproxilfumarat - filmovertrukne tabletter - 200+245 mg
emtricitabin/tenofovirdisoproxil "tillomed" 200+245 mg filmovertrukne tabletter
tillomed pharma gmbh - emtricitabin, tenofovirdisoproxilfumarat - filmovertrukne tabletter - 200+245 mg
emtricitabine/tenofovir disoproxil "sandoz" 200+245 mg filmovertrukne tabletter
sandoz a/s - emtricitabin, tenofovirdisoproxil - filmovertrukne tabletter - 200+245 mg
genvoya
gilead sciences ireland uc - elvitegravir, cobicistat, emtricitabine, tenofovir alafenamide - hiv infektioner - antivirale midler til systemisk anvendelse - genvoya er indiceret til behandling af voksne og unge (alderen 12 år og ældre med kroppen vægt mindst 35 kg) inficeret med human immundefekt virus 1 (hiv 1) uden nogen kendt mutationer i forbindelse med modstand mod integrase inhibitor klasse, emtricitabine eller tenofovir.